banner

The official advocacy organization for pharmacist women in the United States

Advertisement

Pharmacist Moms Group

45,000+ Members

45,000+ Members

Over 6 Million posts, comments and reactions in 2020

Over 6 Million posts, comments and reactions in 2020

60,000+ Followers on social media platforms

60,000+ Followers on social media platforms

The Largest Community of Women Pharmacists in the US

pharmacist moms

Founded in 2017, Pharmacists Moms Group was created to provide women pharmacists the opportunity to network, collaborate and offer genuine feedback in a closed-door, trusted setting. The organization has quickly grown to over 45,000 members and 60,000 followers on our social media platforms.

Pharmacy News
View More
NK3 as a Drug Target: From Scientific Discovery to Guideline-Recognized Therapy

New NK3 receptor blockers target hypothalamic ‘KNDy’ neurons, offering

KNDy Neurons Explained: The Brain Science Behind Hot Flashes and New Treatment Targets

How pharmacists can spot menopause beyond hot flashes, update hormone therapy knowledge, and collaborate on dosing amid estrogen patch shortages.

Vigilance in an Age of Misinformation: Rebuilding Trust Through Evidence and Connection

A reflection from HOPA 2026 explores medical misinformation and how oncology pharmacists can strengthen trust and guide evidence-based patient care.

Tarlatamab Improves Intracranial Outcomes and May Overcome Poor Prognosis in Relapsed SCLC With Brain Metastases

New data from the phase 3 DeLLphi-304 trial suggest tarlatamab significantly improves intracranial efficacy outcomes, CNS progression-free survival, and overall survival in patients with relapsed small cell lung cancer (SCLC) and baseline brain metastases.

ADA 2026: Could a Past GDM Diagnosis Signal Future T1D?

Jessica Dunne, PhD, discusses why adult type 1 diabetes (T1D) is frequently misdiagnosed as T2D in patients with gestational diabetes mellitus (GDM) and how autoantibody testing could close the diagnostic gap.

ADA 2026: Key Challenges in Optimizing Cardio-Renal Risk in Diabetes

Pharmacy Times interviews Tracey Taveira, Pharm.D., CDOE, CVDOE, on the key challenges she discovered in optimizing cardio-renal risk in diabetes that she presented in ADA 2026.

Advertisement
Advertisement

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy